Variables

Frequencies

Pourcentage (%)

Tumour Stage

Localized PCa

23

7.2

Localized low risk

13

4.08

Localized intermediate risk

10

3.18

Localized high risk

7

2.20

Locally advanced PCa

116

36.5

Metastatic PCa

179

56.3

Therapeutic aspects

Radical Prostatectomy

10

3.18

Bilateral pulpectomy (surgery castration)

71

22.3

Antiandrogen

161

50.6

Bilateral Pulpectomy + Antiandrogen

23

7.25

LHRH analogue

15

4.75

Evolution (1 year)

Survival rate

291

91.50

Mortality rate

27

8.50

Local recurrence after prostatectomy

9

3